Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
An examination of the relationship between specific driver mutations, target drugs, and immunotherapies in non-small cell lung cancer survival outcomes. Lauren Connell Independent PLCO Nov 17, 2020 PLCO-691
An explainable liver disease screening-based machine learning model AngĂ©lica AtehortĂșa ISGlobal Barcelona Institute for Global Health PLCO Oct 17, 2024 PLCO-1712
Angiogenic Profile and Risk of Breast Cancer in Postmenopausal Women Roni Falk NCI PLCO Sep 24, 2010 2010-0205
An integrative validation study of circulating glycans, metabolites, lipids, autoantibodies and proteins as biomarkers for lung cancer early detection Ayumu Taguchi MD Anderson Cancer Center PLCO May 1, 2013 2013-0041
An interdisciplinary approach to investigate factors influencing the changes in age-specific incidence of ovarian cancer. Imogen Rogers University of Sussex PLCO Jul 8, 2024 PLCO-1605
Annotation-Ecient Medical Image Analysis Jianming Liang Arizona State University PLCO Apr 25, 2022 PLCOI-880
Anomaly Detection in Lung CT Scans through AWS SageMaker: A Machine Learning Approach Emma Kang University of California at Berkeley NLST Mar 11, 2024 NLST-1202
A novel accuracy metric for general M-class classification when subclasses are involved Nan Nan State University of New York at Buffalo PLCO Apr 29, 2024 PLCO-1531
A Novel Approach to Facilitate Interoperability between Clinical Decision Support Systems and Electronic Health Records Ran Wei Rutgers University - New Jersey Medical Shcool NLST May 26, 2016 NLST-222
A novel approach to lung cancer detection and prediction using biomechanics-enhanced artificial intelligence Hadi Nia Boston University NLST Jan 18, 2019 NLST-471
A novel class prediction algorithm for the analysis of nodules in NLST Emmanuel Zachariah UMDNJ-Robert Wood Johnson Medical School NLST Jun 25, 2013 NLST-24
A Novel Model for Performance Optimization of Reinforcement Learning (RL) Agent in Stochastic Clinical Scenarios Madeha Arif National University of Sciences and Technology, Islamabad Pakistan PLCO Sep 27, 2021 PLCO-837
Anti-inflammatory, Urological, and Reproductive Factors Associated with Risk of Bladder Cancer Sarah Daughterty NCI, DCEG, OEEB PLCO Dec 12, 2006 2006-0316
Anti-Mullerian Hormone and Prostate Cancer Risk Martha Sklavos NCI, DCEG, IIB PLCO Mar 4, 2013 2013-0008
An update of the clinical and cost-effectiveness of lung cancer screening by low-dose CT Chris Hyde University of Exeter NLST Jun 5, 2019 NLST-519
APC Polymorphic Variants in Colon Tumors in the PLCO Trial Ellen Velie Michigan State University PLCO Jul 1, 2006 2006-0254
A Phase II extension of the use of cg05575921 Methylation to predict risk for lung cancer Robert Philibert Behavioral Diagnostics PLCO Aug 1, 2022 2022-0014
Application and Analysis of Mathematical tools in biological model Priya Dubey Amity University PLCO Mar 2, 2022 PLCO-934
Application and evaluation of Deep Learning to Predict tumors in medical images annotated using crowdsourcing Aakanksha Sanctis Maastricht University,Intitute of Data Science NLST Oct 15, 2019 NLST-587
Application of deep learning to automate detection of lung nodules on single and serial chest radiographs Kartik Varadarajan Visionairy Health Inc. PLCO Mar 15, 2021 PLCOI-748